ACD/Labs Signs Reseller Agreement with Applied Biosystems/MDS SCIEX
News Mar 30, 2006
ACD/Labs has announced that it has entered into a reseller's agreement with Applied Biosystems Group, an Applera Corporation business, together with its joint venture partner MDS Sciex, a division of MDS, Inc.
This agreement allows Applied Biosystems/MDS Sciex to sell ACD/Labs' MS Manager, MS Fragmenter, and ChemSketch Software in combination with Applied Biosystems/MDS Sciex mass spectrometry products worldwide.
Under the agreement, ACD/Labs retains responsibility for customer training and technical support of ACD/Labs software.
Antony Williams, VP and Chief Science Officer for ACD/Labs, comments, "ACD/Labs has had a long-term relationship with Applied Biosystems/MDS Sciex supporting the various mass spectrometry file formats developed by MDS Sciex over the past five years."
"Researchers worldwide have benefited from the synergies of our respective products and have encouraged a deeper relationship between our organizations."
"The reseller agreement is a natural extension to our interactions and we look forward to a long and mutually beneficial partnership."
"By offering our customers easy access to both Applied Biosystems/MDS Sciex and ACD/Labs technology, we are able to provide a leading edge, end-to-end solution for LC/MS/MS-based structural identification," adds Byron Kieser, Director of Small Molecule System Solutions at Applied Biosystems.
"We look forward to continuing the excellent relationship with ACD/Labs and to further enhancing the links between our respective products."
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019